Skip to main content

Advertisement

Fig. 4 | BMC Cancer

Fig. 4

From: IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Fig. 4

The expression level of IFI44L decreased in HCC tumor tissues. a The level of IFI44L was examined by IHC staining in 217 pairs of HCC tumor tissues and their adjacent normal tissues (**, P < 0.01). b Images of Western blotting analyses of IFI44L protein level in ten matched pairs of HCC tumor tissues and adjacent normal tissues. The actin was used as an internal control. Relative band intensity was quantified by ImageJ 1.42 and was represented with normalized mean ± s.e. (n = 3) below each band

Back to article page